Achim H Krotz

Title: Achim H. Krotz: Innovations in Oligonucleotide Synthesis

Introduction

Achim H. Krotz, an accomplished inventor based in Irvine, California, has made significant contributions to the field of oligonucleotide synthesis. With an impressive portfolio of 14 patents, his innovative techniques have addressed critical challenges in the manufacturing of oligonucleotides.

Latest Patents

Among his latest inventions, Krotz developed a method for producing chloral-free dichloroacetic acid in oligonucleotide synthesis. This process involves a 5'-deblocking step where the 5-blocking group is removed using dichloroacetic acid that is virtually free of chloral. This innovation minimizes the presence of chloral adducts in oligonucleotides, enhancing their purity and safety.

Additionally, Krotz introduced a process for oligonucleotide synthesis utilizing alternative solvents. This method includes steps such as deblocking a 5' blocked-nucleoside and oxidizing a trivalent phosphite triester to form a pentavalent phosphate triester, with toluene used as a washing solvent in the processes. These advancements in synthesis demonstrate his commitment to improving oligonucleotide manufacturing methods.

Career Highlights

Achim H. Krotz is a vital member of Isis Pharmaceuticals, Inc., where he leverages his expertise in chemical processes to drive innovation in biopharmaceutical development. His work directly impacts the efficiency of oligonucleotide synthesis, advancing both research and therapeutic applications.

Collaborations

Throughout his career, Krotz has collaborated with notable colleagues, including Daniel C. Capaldi and Vasulinga T. Ravikumar. These partnerships have fostered a dynamic research environment and contributed to the successful development of novel methodologies in his field.

Conclusion

Achim H. Krotz exemplifies the role of inventors in enhancing scientific processes within the biopharmaceutical industry. His 14 patents reflect not only his creativity but also his dedication to advancing oligonucleotide synthesis. Through innovative approaches, he continues to contribute significantly to the growth of biotechnology and the development of new therapeutic solutions.